Wednesday, January 27, 2010
quick search - ovarian cancer - Clinical Research as at 1/28/2010 9:51 pm EST
There are 5 clinical trials at NIH that match your search criteria
Cancer by type/disease: Ovarian Cancer
A Phase II Study of Sorafenib and Bevacizumab in Epithelial Ovarian, Fallopian, and Peritoneal Cancer
A Phase II Study of Sorafenib and Bevacizumab in Epithelial Ovarian, Fallopian, and Peritoneal Cancer Clinical, Genetic, Behavioral, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
A Phase I Study With an Expansion Cohort of the PARP Inhibitor AZD2281 (KU-0059436) Combined With Carboplatin in Breast and Ovarian Cancer in BRCA 1/2 Mutation Carriers, Familial Breast and Ovarian Cancer, and Sporadic Triple Negative Breast Cancer and Ovarian Cancer
A Phase I, Open-Label Study of MEDI-547 to Evaluate the Safety, Tolerability, Pharmacokinetics, and Biologic Activity of Intravenous Administration in Subjects With Refractory Solid Tumors Associated With EphA2 Expression
A Phase I Study of Dasatinib in Combination With Bevacizumab in Advanced Solid Tumors
Healthcare-Associated Infection: Not on My Watch - Kimberly-Clark Health Care
"When someone develops an infection at a hospital or other patient care facility that they did not have prior to treatment, this is referred to as a healthcare-associated (sometimes hospital-acquired) infection (HAI).
Healthcare-associated infections (HAIs) are a global crisis affecting both patients and healthcare workers.
According to the World Health Organization (WHO), at any point in time, 1.4 million people worldwide suffer from infections acquired in hospitals."
A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer- Molecular Endocrinology
"Our experiments have revealed strong candidate miRNAs and their target genes that may contribute to the pathogenesis of clear cell ovarian cancer, thereby highlighting alternative therapeutic strategies....."
Columns - Focus on Policy - Outliers: The Story of Success
"Gladwell asks why it is so difficult to acknowledge the fact that each of us comes from a culture with its own distinctive mix of strengths and weaknesses, tendencies, and predispositions. "Who we are cannot be separated from where we are from -- and when we ignore that fact, planes crash."
And patients die."
Why doctors' stories matter
"...As I read the winning stories, I had a fantasy, which is probably not a good idea to apply literally, but it’s useful as what philosophers would call a thought experiment. My fantasy was that in a doctor’s waiting room, instead of old magazines and public health brochures, patients might pick up stories that the doctor had written—stories not unlike these winning stories. And maybe patients would then bring in their stories and leave copies of those on the rack next to the doctor’s stories. That would open the silent world on both sides."
Does computer use in patient-physician encounters influence patient satisfaction?
EDITOR’S KEY POINTS
- Patient-physician communication is central to every physician’s practice and to patient satisfaction. Physicians have been concerned that the introduction of computers into patient consultations will lead to a breakdown of communication.
- This study sought to examine patients’ opinions about the effects of computer use on patient-physician interaction and on their satisfaction with their visits.
- Results of this study suggest that concerns about computer use negatively affecting patient-physician relationships and patient satisfaction are largely unfounded. Most patients had no preference for whether computers were used or not, and computer use actually seemed to have a positive effect on overall satisfaction. Other studies have shown that patients’ main concerns about computer use have to do with privacy, but in this study only 3.4% of respondents were concerned about a "negative" or "very negative" effect on privacy.
Interview: The Health 2.0 Blog: ACOR, Health 2.0 in the US & Europe: Gilles Frydman tells all
"Gilles Frydman is one of the leading ePatients. He started and runs ACOR (Association of Cancer Online Resources) and has discussed the role of engaged patients with rare diseases at the last few Health 2.0 Conferences."
Subscribe to:
Posts
(
Atom
)
